Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Share This Author
Drug safety discontinuations in the United Kingdom, the United States, and Spain from 1974 through 1993: A regulatory perspective
- O. Bakke, M. Manocchia, F. Abajo, K. Kaitin, L. Lasagna
- Political ScienceClinical pharmacology and therapeutics
- 1 July 1995
Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications
- V. Abbing-Karahagopian, C. Huerta, M. L. Bruin
- MedicineEuropean Journal of Clinical Pharmacology
- 3 May 2014
TLDR
Ascertainment of acute liver injury in two European primary care databases
- A. Ruigómez, R. Brauer, O. Klungel
- MedicineEuropean Journal of Clinical Pharmacology
- 29 July 2014
TLDR
Use of Antihypertensive Drugs in Spain (1995-2001)
- J. G. Pozo, Eduardo Ramos Sevillano, F. Abajo, R. M. Campos
- Medicine, Political Science
- 1 March 2004
Global oa management begins with quality of life assessment in knee oa patients: a systematic review
- J. Vergés, M. Vitaloni, A. B. Bemden
- MedicineOsteoarthritis and Cartilage
- 1 April 2019
For peer review only 1 TITLE ORAL BISPHOSPHONATES ARE ASSOCIATED WITH INCREASED RISK OF ATYPICAL FEMORAL FRACTURES IN ELDERLY WOMEN
TLDR
AB0814 INDIVIDUAL AND SOCIAL FACTOR CAN INFLUENCE THE QUALITY OF LIFE OF KNEE OA PATIENTS: A SYSTEMATIC REVIEW
- J. Vergés, M. Vitaloni, A. B. Bemden
- Medicine, PsychologyAbstracts Accepted for Publication
- 1 June 2019
Background Knee OA (KOA) is the most common form of chronic joint disease and bears more responsibility than any other disease for disability1. It associates with remarkable functional restrictions…
How small risk ratios may have strong public health impact. The case of nimesulide
- A. Carvajal, M. Macía, J. G. Pozo, F. Abajo, DoloresMontero, F. D. Andrés
- Medicine
- 15 June 2018
Abstracts
- P. Souverein, E. Martín, H. Gardarsdottir
- Medicine, BiologyPharmacoepidemiology and drug safety
- 1 October 2014
TLDR
...
...